Recent developments in the legal battle over the planned $3.3 billion UnitedHealth Group (NYSE: UHG) acquisition of Amedisys (Nasdaq: AMED) have moved the ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
GMO's portfolio update highlights key stock adjustments and forecasts a promising 9.6% return for International Deep Value ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback